Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price gains.

The biotech revolution spent decades trying to harness power for medicine. The next chapter is harnessing it for everything ...

He said U.S. losses alone top $500 billion a year and called gene drives “the only scalable” solution. As reported by 24/7 ...

Generate Biomedicines Inc. advanced stock charts by Barron's. View GENB historical stock data and compare to other stocks, and exchanges.

The cover of National Geographic’s March issue featured a tractor tire dangling from a thread. Not metaphorically, but literally, because the thread is spider silk — five times stronger than steel but ...

Spread the loveThe stock market is a constantly evolving landscape, with companies rising and falling based on a myriad of factors. As of April 11, 2026, significant news has emerged, particularly ...

If Biotech manages to break out to new highs at some point this year, it would clear a significant resistance hurdle and open ...

Investing in small biotech companies that make sufficient progress in regulatory approval and commercialization can ...

As demand for synthetic peptide compounds in British academic and biotech laboratories reaches record levels, Syntech ...

China’s biotechs are faster and have lower costs, and its drug research threatens to soon overtake the West’s ...

Two days after the arrest of a suspect in what police said was a Feb. 15 murder in a Miami Beach high-rise, a man who knew ...